Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cyanotech Corporation
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2009
March 1st, 2009
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in producing high-value nutrition and health products from microalgae, announced financial results for the third quarter and first nine months of fiscal 2009, ended December 31, 2008. Revenues for the third quarter of fiscal 2009 increased 28.6% to $3,553,000, compared to revenues of $2,763,000 for the third quarter of fiscal 2008. Gross profit for the third quarter was $1,566,000, with gross profit margin of 44.1%, compared to a gross profit of $353,000 and gross profit margin of 12.8% reported for the same quarter of the prior year. Net income for the third quarter was $514,000, or $0.10 per diluted...
Source: Pharma Investments, Ventures & Law Weekly (2009-03-01)
|
